Sector Update: Health-care Stocks Flat Pre-Market

By
A A A

Top Health-care stocks:

JNJ: -1.30%

PFE: flat


ABT: flat

MRK: flat

AMGN: flat

Health-care shares were flat in pre-market trade Monday.

In health-care stocks news, Arena Pharmaceuticals ( ARNA ) says its wholly-owned subsidiary, Arena Pharmaceuticals GmbH, has entered into an exclusive marketing and supply agreement for BELVIQ (lorcaserin HCl) with Teva Pharmaceutical Industries Limited's local Israeli subsidiary, Abic Marketing Limited.

And, Genocea Biosciences ( GNCA ) has announced the start of a Phase 2 dose optimization trial for GEN-003, the company's immunotherapy candidate against herpes simplex-type 2 (HSV-2).

The Phase 2 dose optimization study will enroll approximately 300 subjects from 17 institutions in the United States and will study six combinations of two antigen doses.

Finally, Sequenom ( SQNM ), provider of molecular diagnostic testing and genetics analysis services, Monday said that its Sequenom Laboratories subsidiary will soon launch VisibiliT prenatal testing technology.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


This article appears in: Investing , Commodities

Referenced Stocks: ARNA , GNCA , SQNM

MT Newswires

MT Newswires

More from MT Newswires:

Related Videos

Stocks

Referenced

Most Active by Volume

33,110,376
  • $113.99 ▲ 1.77%
25,034,179
    $17.98 unch
24,486,872
  • $7.41 ▲ 2.07%
20,864,535
  • $7.39 ▼ 2.76%
18,600,501
  • $8.30 ▼ 0.36%
17,530,211
  • $8.14 ▲ 3.17%
17,299,208
  • $93.79 ▲ 2.74%
14,669,760
  • $25.78 ▼ 0.19%
As of 12/26/2014, 04:15 PM


Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com